Your browser doesn't support javascript.
loading
Anti-hepatitis C Virus Activity of Juglorubin Derivatives.
Ohashi, Hirofumi; Nishioka, Kazane; Kurihara, Tomoki; Nakamura, Kou; Yamasaki, Masako; Ibayashi, Yuuka; Fuchiyama, Kanta; Kamo, Shogo; Furuyama, Yuuki; Ohgane, Kenji; Okada, Maiko; Kamisuki, Shinji; Watashi, Koichi; Kuramochi, Kouji.
Afiliação
  • Ohashi H; Department of Applied Biological Science, Tokyo University of Science.
  • Nishioka K; Department of Virology II, National Institute of Infectious Diseases.
  • Kurihara T; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases.
  • Nakamura K; Department of Applied Biological Science, Tokyo University of Science.
  • Yamasaki M; Department of Virology II, National Institute of Infectious Diseases.
  • Ibayashi Y; Department of Applied Biological Science, Tokyo University of Science.
  • Fuchiyama K; Department of Virology II, National Institute of Infectious Diseases.
  • Kamo S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases.
  • Furuyama Y; School of Veterinary Medicine, Azabu University.
  • Ohgane K; Department of Applied Biological Science, Tokyo University of Science.
  • Okada M; Department of Virology II, National Institute of Infectious Diseases.
  • Kamisuki S; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases.
  • Watashi K; Department of Applied Biological Science, Tokyo University of Science.
  • Kuramochi K; Department of Applied Biological Science, Tokyo University of Science.
Chem Pharm Bull (Tokyo) ; 71(11): 843-845, 2023.
Article em En | MEDLINE | ID: mdl-37914261

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Limite: Humans Idioma: En Revista: Chem Pharm Bull (Tokyo) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatite C / Hepacivirus Limite: Humans Idioma: En Revista: Chem Pharm Bull (Tokyo) Ano de publicação: 2023 Tipo de documento: Article